• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS HIGH SAMPLE DILUENT A REAGENT PACK; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS HIGH SAMPLE DILUENT A REAGENT PACK; IN-VITRO DIAGNOSTICS Back to Search Results
Catalog Number 8430373
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/29/2021
Event Type  malfunction  
Manufacturer Narrative
The assignable cause for the lower than expected vitros tsh results was an incorrect value for the tsh baseline concentration for vitros hsda lot 2190 on the assay data disk (add) / mag card.It was determined that the baseline tsh concentration for hsda lot 2190 was incorrectly defined in the add/mag card as 112 miu/l instead of 0.112 miu/l.The baseline tsh concentration is subtracted out of the final numerical tsh result when an on-board dilution is performed.The incorrect hsda value (112 miu/l versus 0.112 miu/l) impacted the calculated tsh result leading to negatively biased tsh results when the sample was diluted.(b)(4).
 
Event Description
The investigation determined that lower than expected tsh results were obtained from a non-patient micro audit calibration verification fluid when tested using an on-board 2x dilution when compared to the tsh result tested undiluted using vitros tsh reagent lot 6610 on two different vitros 5600 systems.Tsh 2x diluted results of 9.48 and 11.8 miu/l versus undiluted tsh result of >100 miu/l.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The lower than expected vitros tsh results were obtained from a non-patient micro audit calibration verification fluid.If the event were to recur with patient samples it would be anticipated that the discordancy between the undiluted and diluted results would be detectable upon result review.The customer made no indication patient sample results were affected and there was no allegation of patient harm as a result of this event.This report is number one of two mdr¿s for this event.Two 3500a forms are being submitted for this event as two devices were involved.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4).
 
Manufacturer Narrative
Ortho has reported this as a class iii recall to oradevices1recalls@fda.Hhs.Gov on 22 november 2021.A communication (cl2021-287) was sent on 22 november 2021 to customers who have been shipped vitros high sample diluent a (hsda) lot 2190.The communication advised customers of the issue with lower than expected tsh results when using hsda lot 2190 for onboard dilution and advised that vitros hsda lot 2190 be discontinued to dilute samples tested with vitros tsh reagent.The communication indicates that if their facility does not use the vitros tsh assay, they may continue to use the vitros hsda lot 2190.However, if their facility does use the vitros tsh assay, ortho will replace their inventory of hsda lot 2190.
 
Event Description
This supplemental mdr report was created to document this event was reported as a class iii recall and a communication was sent to customers.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS HIGH SAMPLE DILUENT A REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key12865452
MDR Text Key282116921
Report Number3007111389-2021-00152
Device Sequence Number1
Product Code PPM
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Remedial Action Notification
Type of Report Initial,Followup
Report Date 12/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/09/2022
Device Catalogue Number8430373
Device Lot Number2190
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 10/29/2021
Initial Date FDA Received11/23/2021
Supplement Dates Manufacturer Received10/29/2021
Supplement Dates FDA Received12/08/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/29/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-